BRCA1 and ovarian neoplasm: This finding was further confirmed in a BRCA1 mutant ovarian tumor line (UWB1.289) (Supplementary Fig. 2i) and in cells depleted of BRCA1 with an additional siRNA targeting BRCA1 (Supplementary Fig. 2j–k).